HomeNON PROFITAmerican College of Cardiology Names Ravee Kurian COO/CFO

American College of Cardiology Names Ravee Kurian COO/CFO

American College of Cardiology reports Ravee Kurian has been named Executive Vice President and Chief Operating Officer/Chief Financial effective July 1. Kurian will lead the global organization’s strategic planning, finance and technology divisions, while working closely with the ACC’s leadership team to advance the College’s digital transformation initiatives.

When the world was hit by the biggest public health crisis of our lifetimes, the ACC’s Board and Staff pivoted quickly to accommodate the rapidly shifting needs of the organization and its members,” Kurian said. “The ACC’s ability to do this without skipping a beat demonstrated exceptional levels of professionalism and commitment by every single person involved. I am honored and humbled to join this dedicated group as a member of the leadership team and I look forward to helping the College move confidently into the future.”

Kurian comes to ACC following a 20-year stint at Publicis Sapient, a leading technology and communications consultancy, where he led critical and sensitive digital transformation initiatives for Fortune 500 and U.S. federal clients.

Over the course of his career, Kurian has worked in a broad range of industries, including aerospace, trucking, insurance, defense and medical research. His most recent experience has been at the National Institutes of Health (NIH) where he worked with researchers, physicians and content strategists to develop a digital-first mindset that helped align their technology investments with how their audiences were interacting with their content. Previously, he also worked at Ernst & Young and at Landauer Associates, a real estate valuation and research firm.

Kurian holds a Master of Business Administration from the Kellogg School of Management at Northwestern University and a Bachelor of Science from the University of Massachusetts at Amherst.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

Don't Miss

Hinge Health Acquires the Most Advanced Computer Vision Technology for Tracking Human Motion

CEO Daniel Perez explained, “We won’t stop investing in technology to deliver the most patient-centered digital clinic that improves member experience and outcomes while reducing costs. wrnch allows us to take a giant leap forward in all respects.”

Dale W Wood Congratulates the Huma Team on Raising $130 Million

Major health and technology companies across the world have committed upwards of $130 million to Huma Therapeutics, the health-tech company backed by Dale Ventures.

Rhaeos Awarded $4 Million NIH SBIR Grant

Under the NIH SBIR grant, Rhaeos will leverage their existing wireless sensor hardware to provide additional quantitative flow data to the clinician, giving insight into this currently inaccessible and highly relevant shunt performance metric.

Gynesonics Announces FDA Clearance of Next Generation Sonata System

“This clearance brings significant system improvements that expand the location of fibroids that can be treated while allowing the physician to control all aspects of the treatment from within the sterile field,” said Jiayu Chen, Ph.D. Vice President, Engineering and Advanced Technologies at Gynesonics.

Blackrock Neurotech Invests In Groundbreaking Auditory Nerve Implant With University Of Minnesota And MED-EL

The new investment will enable the development and translation of a new ANI through preclinical studies and later, a pilot clinical trial, where the ANI is then implanted in up to three deaf patients.

Jonathan Chapman: New President/CEO of Trividia Health

Chapman said, “I’m honored to join the Trividia team as President and CEO. This organization has a long history of leadership within the healthcare industry as a provider of accurate, accessible, and affordable point-of-care solutions for the management of diabetes.”

SOLOPASS® System (Bedside Neuro-Navigation Device) Receives FDA 510(k) Clearance

inTRAvent’s SOLOPASS® system brings simple, portable, bedside neuro-navigation into the intensive care unit.

Skyhawk Therapeutics Completes New Investment Round

A $133 million round of investment will allow Skyhawk to accelerate development of its novel small molecule RNA-modifying drug candidates into the clinic.

By using this website you agree to accept Medical Device News Magazine Privacy Policy